Home LiteratureArticle Details
PMID: 2286021 Published · ppublish English Case Reports Journal Article

Late malignant recurrence of childhood cerebellar astrocytoma.

Clinical neuropathology ·Vol. 9 ·No. 6 ·1990-00-00 ·Pages 295-8

Casadei GP, Arrigoni GL, D'Angelo V, Bizzozero L

Abstract

Juvenile pilocytic astrocytoma of the cerebellum has a benign course and a good prognosis. We report a case of juvenile cerebellar astrocytoma in a 6-year-old girl that underwent surgical resection of the tumor and had two recurrences, 13 and 35 years after first removal. After surgery the patient did not receive any radiation therapy. The last relapse showed histological features of an anaplastic astrocytoma. Six months later the patient died with a diffuse leptomeningeal dissemination. Late malignant transformation of a benign cerebellar astrocytoma is very rare and it is thought to be favored by postsurgical irradiation. The possible pathogenetic mechanisms of this evolution are discussed. This case and the few others reported in the literature emphasize the risk of an unpredictable outcome with the low-grade cerebellar astrocytomas of childhood.

MeSH Terms
Adolescent Adult Astrocytes/pathology Astrocytoma/pathology,surgery Brain Stem/pathology Cerebellar Neoplasms/pathology,surgery Cerebellum/pathology Cerebral Ventricles/pathology Child Female Follow-Up Studies Humans Neoplasm Recurrence, Local/pathology,surgery Reoperation
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Casadei G P
Service of Anatomical Pathology, Niguarda Hospital, Milan, Italy.
Arrigoni G L
D'Angelo V
Bizzozero L
Article Info
Journal
Clinical neuropathology
Abbr.
Clin Neuropathol
ISSN
0722-5091
Published
1990-00-00
Pages
295-8
Language
English
Region
Germany
NLM ID
8214420
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com